M. Leitch

421 total citations
12 papers, 347 citations indexed

About

M. Leitch is a scholar working on Cancer Research, Oncology and Epidemiology. According to data from OpenAlex, M. Leitch has authored 12 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in M. Leitch's work include Breast Cancer Treatment Studies (7 papers), Estrogen and related hormone effects (2 papers) and Global Cancer Incidence and Screening (2 papers). M. Leitch is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Estrogen and related hormone effects (2 papers) and Global Cancer Incidence and Screening (2 papers). M. Leitch collaborates with scholars based in United States, Australia and Switzerland. M. Leitch's co-authors include Veena R. Agarwal, E R Simpson, Serdar E. Bulun, Rachel N. Rohrich, Elizabeth Ward, Michael T. Halpern, Nicole M. Schrag, Andrew K. Stewart, Roshni Rao and Asal Rahimi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

M. Leitch

12 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Leitch United States	4	195	136	102	92	48	12	347
Susanne Schüler‐Toprak Germany	13	140 0.7×	119 0.9×	96 0.9×	136 1.5×	24 0.5×	23	378
Judy-Anne W. Chapman Canada	8	138 0.7×	185 1.4×	124 1.2×	85 0.9×	68 1.4×	9	358
Ian Laidlaw United Kingdom	5	145 0.7×	181 1.3×	110 1.1×	115 1.3×	38 0.8×	12	351
Prasenjit Dey United States	7	183 0.9×	106 0.8×	79 0.8×	177 1.9×	22 0.5×	10	357
Gen Matsunaga Japan	10	173 0.9×	156 1.1×	44 0.4×	131 1.4×	36 0.8×	12	482
Ai Li Yeo Australia	7	170 0.9×	77 0.6×	56 0.5×	220 2.4×	32 0.7×	17	407
Anna Hester Germany	12	70 0.4×	115 0.8×	97 1.0×	174 1.9×	29 0.6×	42	437
Sonia Godoy‐Tundidor Austria	12	122 0.6×	183 1.3×	161 1.6×	253 2.8×	39 0.8×	14	547
Snježana Frković Grazio Slovenia	13	68 0.3×	96 0.7×	53 0.5×	149 1.6×	31 0.6×	23	323
Regina Courtney United States	10	99 0.5×	97 0.7×	89 0.9×	195 2.1×	22 0.5×	17	458

Countries citing papers authored by M. Leitch

Since Specialization

Citations

This map shows the geographic impact of M. Leitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Leitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Leitch more than expected).

Fields of papers citing papers by M. Leitch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Leitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Leitch. The network helps show where M. Leitch may publish in the future.

Co-authorship network of co-authors of M. Leitch

This figure shows the co-authorship network connecting the top 25 collaborators of M. Leitch. A scholar is included among the top collaborators of M. Leitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Leitch. M. Leitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rahimi, Asal, M. Leitch, Başak E. Doğan, et al.. (2023). Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(4). e7–e8. 2 indexed citations

Leitch, M., et al.. (2023). Group B streptococcus in the Northern Territory in 2023: clindamycin down but not out. Communicable Diseases Intelligence. 47. 2 indexed citations

Sher, David J., M. Leitch, J.A. Haas, et al.. (2023). Financial Toxicity and Patient Experience Outcomes on a Multi-Institutional Phase I Single Fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e259–e260. 1 indexed citations

Rahimi, Asal, M. Leitch, Xuejun Gu, et al.. (2021). Early Follow-Up of Multi-Institutional Trial of Phase I Dose Escalation Using Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 111(3). e228–e228. 3 indexed citations

Vo, Dat T., Asal Rahimi, Joyce O’Shaughnessy, et al.. (2017). Long-Term Results of a Prospective Pilot Safety and Feasibility Study of Adjuvant Concurrent Capecitabine and External Beam Irradiation Demonstrates Tolerability and Efficacy in High-Risk Locally Advanced Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). S215–S215. 1 indexed citations

Thomas, K., Asal Rahimi, Roshni Rao, et al.. (2016). Aspirin/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. Breast Cancer Research and Treatment. 161(3). 463–471. 31 indexed citations

Rahimi, Asal, K. Thomas, Ann Spangler, et al.. (2016). Phase 1 Dose Escalation Trial Using 5-Fraction Stereotactic Body Radiation Therapy For Partial Breast Irradiation (S-PBI). International Journal of Radiation Oncology*Biology*Physics. 96(2). S7–S8. 1 indexed citations

Rahimi, Asal, Ann Spangler, Dan Garwood, et al.. (2014). Phase 1 Dose Escalation Trial Using Stereotactic Body Radiation Therapy (SBRT) for Partial Breast Irradiation (PBI). International Journal of Radiation Oncology*Biology*Physics. 90(1). S253–S253. 1 indexed citations

Suman, Vera J., Lisa McCall, Rui Luo, et al.. (2012). Abstract PD07-01: Z1031B Neoadjuvant Aromatase Inhibitor Trial: A Phase 2 study of Triage to Chemotherapy Based on 2 to 4 week Ki67 level > 10%.. Cancer Research. 72(24_Supplement). PD07–1. 12 indexed citations

10.

Collins, Rebecca, Alana Christie, M. Leitch, et al.. (2012). Abstract P1-07-04: Comparison of HER2 expression by immunohistochemistry (IHC) using automated imaging system and fluorescence in situ hybridization (FISH). A retrospective analysis of 2853 cases. Cancer Research. 72(24_Supplement). P1–7. 1 indexed citations

11.

Halpern, Michael T., et al.. (2008). Disparities and Trends in Sentinel Lymph Node Biopsy Among Early-Stage Breast Cancer Patients (1998-2005). JNCI Journal of the National Cancer Institute. 100(7). 462–474. 71 indexed citations

12.

Agarwal, Veena R., Serdar E. Bulun, M. Leitch, Rachel N. Rohrich, & E R Simpson. (1996). Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.. The Journal of Clinical Endocrinology & Metabolism. 81(11). 3843–3849. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact